by LCGC-Team | Dec 7, 2015
Developments in oncological positron emission tomography/computed tomography assessment Kobe C, Boellaard R, Wolf J, Kuhnert G, Dietlein M, Neumaier B, Drzezga A, Kahraman D Journal: J Thorac Dis Veröffentlichung: 7. Dezember... by PERIMETRIK® Bonn/Darmstadt | Nov 6, 2015
Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases. Meder L, König K, Fassunke J, Ozretić L, Wolf J, Merkelbach-Bruse S, Heukamp LC, Buettner R. Journal: Exp Mol Pathol Veröffentlichung: 6. November... by PERIMETRIK® Bonn/Darmstadt | Oct 18, 2015
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors. Heigener DF, Schumann C, Sebastian M, Sadjadian P, Stehle I, Märten A, Lüers A, Griesinger F, Scheffler M Journal: Oncologist Veröffentlichung: 20.... by PERIMETRIK® Bonn/Darmstadt | Oct 10, 2015
Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort. Meder L, König K, Ozretić L, Schultheis AM, Ueckeroth F, Ade CP, Albus K, Boehm D, Rommerscheidt-Fuss U, Florin A, T Buhl, Hartmann W, Wolf J, Merkelbach-Bruse S, M... by PERIMETRIK® Bonn/Darmstadt | Sep 4, 2015
NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Meder L, König K, Ozretić L, Schultheis AM, Ueckeroth F, Ade CP, Albus K, Boehm D, Rommerscheidt-Fuss U, Florin A, T Buhl, Hartmann W, Wolf J,...